Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
150,858,761
-
Total 13F shares
-
53,433,471
-
Share change
-
-1,547,050
-
Total reported value
-
$872,653,344
-
Price per share
-
$16.33
-
Number of holders
-
121
-
Value change
-
-$22,171,694
-
Number of buys
-
65
-
Number of sells
-
40
Institutional Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q3 2022
As of 30 Sep 2022,
Avidity Biosciences, Inc. - Common Stock (RNA) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,433,471 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., COWEN AND COMPANY, LLC, FMR LLC, EcoR1 Capital, LLC, T. Rowe Price Investment Management, Inc., VANGUARD GROUP INC, Avidity Partners Management LP, and FEDERATED HERMES, INC..
This page lists
121
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.